3rd Quarter - Report
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
Firm
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R.107: to sunset the limit on maximum rebate amount for single source drugs. H.R.3: Lower Drug Costs Now Act of 2019. Regulatory and legislative proposals in the Administrations Blueprint. H.R.2113: Prescription Drug STAR Act / H.R.2296: FAIR Drug Pricing Act. FY 2020 Continuing Resolution.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Education about innovative contracting and value based payments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.